Arcutis Biotherapeutics Inc (ARQT) USD0.0001

Sell:$24.79Buy:$24.81Price increased$0.81 (3.38%)

NASDAQ:Price increased1.38%
Market closed |
Prices delayed by at least 15 minutes
Sell:$24.79
Buy:$24.81
Change:Price increased$0.81 (3.38%)
Market closed |
Prices delayed by at least 15 minutes
Sell:$24.79
Buy:$24.81
Change:Price increased$0.81 (3.38%)
Market closed |
Prices delayed by at least 15 minutes

Director deals

Listed below are trades carried out by directors and other individuals which are required to be notified to the market.

Recent deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
2 March 2026
Todd Franklin WatanabePresident/CEO
Sell
Tax related
36,281$25.16$912,851.73787,025
2 March 2026
Todd Franklin WatanabePresident/CEO
Sell
Tax related
1,068$25.91$27,676.05785,957
2 March 2026
Larry Todd EdwardsChief Legal/Compliance Officer
Sell
Tax related
3,584$25.16$90,177.02175,281
2 March 2026
Larry Todd EdwardsChief Legal/Compliance Officer
Sell
Tax related
103$25.91$2,669.23175,178
2 March 2026
Masaru (Mas) MatsudaChief Legal/Compliance Officer
Sell
Tax related
6,553$25.16$164,876.10137,125
2 March 2026
Masaru (Mas) MatsudaChief Legal/Compliance Officer
Sell
Tax related
193$25.91$5,001.38136,932
2 March 2026
Masaru (Mas) MatsudaChief Legal/Compliance Officer
Sell
Regular sell transaction (market)
1,987$25.70$51,065.90136,932
2 March 2026
Patrick BurnettOther Level A
Sell
Tax related
6,106$25.16$153,629.40121,295
2 March 2026
Patrick BurnettOther Level A
Sell
Tax related
181$25.91$4,690.43121,150
2 March 2026
Latha VairavanCFO
Sell
Tax related
2,772$25.16$69,744.9187,835

5 most significant deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
24 November 2025
Todd Franklin WatanabePresident/CEO
Sell
Regular sell transaction (market)
48,945$30.36$1,485,754.84740,537
28 October 2025
Todd Franklin WatanabePresident/CEO
Sell
Regular sell transaction (market)
40,000$25.03$1,001,032.00806,440
2 March 2026
Todd Franklin WatanabePresident/CEO
Sell
Tax related
36,281$25.16$912,851.73787,025
13 November 2025
Neha KrishnamohanDirector
Sell
Option/Award related
39,272$23.19$910,701.9723,355
24 November 2025
Sue-Jean LinDirector
Sell
Option/Award related
25,272$30.78$777,955.5626,735

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.